(Q44223616)

1 December 2017

title

Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial (English)

1 reference

1 December 2017

2

Yolande Lievens

1 reference

1 December 2017

Karin Stellamans

1

1 reference

1 December 2017

Philippe Lambin

3

1 reference

1 December 2017

Danielle Van den Weyngaert

4

1 reference

1 December 2017

Walter Van den Bogaert

5

1 reference

1 December 2017

Pierre Scalliet

6

1 reference

1 December 2017

Liesbeth Hutsebaut

7

1 reference

1 December 2017

Karin Haustermans

8

1 reference

1 December 2017

publication date

1 November 2002

1 reference

Radiotherapy and Oncology

1 December 2017

published in

1 reference

1 December 2017

volume

65

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

105-108

1 reference

Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Sucralfate in the prevention of radiation-induced oral mucositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

Assessment of sucralfate coating by sequential scintigraphic imaging in radiation-induced esophageal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900281-5

7 January 2021

10.1016/S0167-8140(02)00281-5

Identifiers

DOI

1 reference

1 December 2017

1 reference